Skip to content
sellModerate cluster of 410b5-1 plan

Marc David Benathen sold $1.7M of LFMD

Chief Financial Officer at LifeMD, Inc.. 125,000 shares at an average of $13.46, traded Jun 16, 2025, filed Jun 18, 2025.

Warning score
52
Value
$1.7M
125,000 shares
Holdings after
339,554
-27% from before
From 52-week low
+230%
low $4.08, close $13.47
From 52-week high
0%
high $13.47, as of Jun 16, 2025

Score components

  • Role
    CFO
    +22
  • Trade size
    $1.7M at market
    +25
  • Share of holdings sold
    Sold 27% of holdings
    +10
  • Cluster
    4 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -29.9%, 3m -59.6%, 6m -78.5%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

LFMDOct 12, 2026 · close 2.55
Since filing Jun 18, 2025: -83.1%SPY +32.4% · excess -115.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000912282-25-000692, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 16, 2025SOpen-market sale
Common Stock10b5-1
-75,000$13.09$982k389,554Jun 18, 2025
Jun 17, 2025SOpen-market sale
Common Stock10b5-1
-50,000$14.01$700k339,554Jun 18, 2025

Related signals

Other insiders at LifeMD, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
22Weak
LFMDsell
LifeMD, Inc.
Jessica Friedeman
Chief Marketing Officer
$54k
15,000 shares
-7%
37Weak
LFMDsell
LifeMD, Inc.
Nicholas P Alvarez
Chief Acquisition Officer
$444k
75,000 shares
-11%
18Weak
LFMDsell10b5-1
LifeMD, Inc.
Justin Schreiber
Chairman and CEO
$250k
25,000 shares
-1%
20Weak
LFMDsell10b5-1
LifeMD, Inc.
Justin Schreiber
Chairman and CEO
$334k
25,000 shares
-1%
55Moderate
LFMDsell 410b5-1
LifeMD, Inc.
Stefan Galluppi
Chief Innovation Officer
$1.1M
85,000 shares
-51%
52Moderate
LFMDsell 4
LifeMD, Inc.
Eric Harold Yecies
Chief Legal Officer & GC
$184k
15,000 shares
-48%
34Weak
LFMDsell 410b5-1
LifeMD, Inc.
Justin Schreiber
Chairman and CEO
$312k
25,000 shares
-1%
17Weak
LFMDsell10b5-1
LifeMD, Inc.
Justin Schreiber
Chairman and CEO
$188k
25,000 shares
-1%
21Weak
LFMDsell10b5-1
LifeMD, Inc.
Justin Schreiber
Chairman and CEO
$389k
50,000 shares
-2%
31Weak
LFMDsell
LifeMD, Inc.
Jessica Friedeman
Chief Marketing Officer
$170k
30,000 shares
-15%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Marc David Benathen sold $1.7M of LFMD | InsiderTell